PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
PLIANT THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.90−0.00 (-0.13%)
Close on Oct 19, 2026
- Market cap
- $55.65M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SEC filings
40 of Pliant Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2026 | Mar 11, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 11, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 16, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 20, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 23, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2025 | Feb 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2024 | Sep 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2024 | Jul 15, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 14, 2024 | May 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 6, 2024 | May 6, 2024 | SEC EDGAR |